Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Hexameric procyanidins inhibit colorectal cancer cell growth through both redox and non-redox regulation of the epidermal growth factor signaling pathway - ScienceDirect
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution - ScienceDirect
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies | Personalized Medicine
Y‑box‑binding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer
Les biomarqueurs prédictifs dans le cancer colorectal
Cancers | Free Full-Text | Immune Resistance and EGFR Antagonists in Colorectal Cancer
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
APMG Colon Molecular Pathways
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
EGFR | Cancer Genetics Web
Precision medicine for metastatic colorectal cancer in clinical practice - Julian E. Riedesser, Matthias P. Ebert, Johannes Betge, 2022
New combination therapy offers bowel cancer patients extra treatment option
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
The Role of the Epidermal Growth Factor Receptor in the Mechanism and Treatment of Colorectal Cancer - Nirit Yarom - Discovery Medicine
Colorectal adenocarcinoma‐derived EGFR mutants are oncogenic and sensitive to EGFR‐targeted monoclonal antibodies, cetuximab and panitumumab - Kim - 2020 - International Journal of Cancer - Wiley Online Library
Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells | Oncotarget
Different EGFR signalling pathways induced by the interaction between... | Download Scientific Diagram
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
